Zydus Lifesciences Limited has informed the Exchange regarding a press release dated July 07, 2023, titled "USFDA inspection at Zydus formulation manufacturing facility at SEZ 2, Ahmedabad concludes with nil observations".
Press Release Jul 07 2023
Filed with NSE · · 2 pages · English
Summary by 6ix AI
Zydus Lifesciences Limited has issued a press release regarding a recent USFDA inspection. The inspection at their formulation manufacturing facility in Ahmedabad concluded with no observations. This announcement serves as a disclosure in accordance with regulatory requirements.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Jul 04 2023
- Press Release Jul 03 2023
- Press Release Jun 28 2023
- Press Release Jun 19 2023
- Press Release Jun 13 2023
Later from Zydus Lifesciences
- Press Release Jul 27 2023
- Press Release Aug 03 2023
- Press Release Aug 11 2023
- Press Release Aug 17 2023
- Press Release Aug 24 2023
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences